Standard BioTools Inc.
LAB
$1.07
-$0.045-4.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 258.06M | 292.87M | 366.33M | 394.71M | 462.28M |
| Total Receivables | 35.48M | 33.61M | 35.32M | 32.44M | 36.01M |
| Inventory | 42.13M | 40.74M | 42.64M | 42.62M | 40.36M |
| Prepaid Expenses | 8.35M | 8.66M | 9.32M | 10.26M | 8.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 344.02M | 375.88M | 453.61M | 480.03M | 547.57M |
|
|
|||||
| Total Current Assets | 344.02M | 375.88M | 453.61M | 480.03M | 547.57M |
| Net Property, Plant & Equipment | 71.02M | 71.38M | 72.25M | 74.10M | 62.25M |
| Long-term Investments | 111.72M | 111.30M | 106.34M | 106.25M | 106.27M |
| Goodwill | 111.72M | 111.30M | 106.34M | 106.25M | 106.27M |
| Total Other Intangibles | 28.06M | 28.95M | 23.37M | 24.08M | 40.29M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.79M | 24.83M | 25.98M | 24.27M | 21.29M |
| Total Assets | 579.60M | 612.34M | 681.54M | 708.73M | 777.67M |
|
|
|||||
| Total Accounts Payable | 11.78M | 12.28M | 10.93M | 12.57M | 13.14M |
| Total Accrued Expenses | 13.99M | 21.61M | 21.66M | 20.98M | 17.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.33M | 6.23M | 61.04M | 60.63M | 60.49M |
| Total Finance Division Other Current Liabilities | 24.14M | 25.78M | 27.00M | 29.63M | 30.38M |
| Total Other Current Liabilities | 24.14M | 25.78M | 27.00M | 29.63M | 30.38M |
| Total Current Liabilities | 56.24M | 65.89M | 120.62M | 123.81M | 121.55M |
|
|
|||||
| Total Current Liabilities | 56.24M | 65.89M | 120.62M | 123.81M | 121.55M |
| Long-Term Debt | 299.00K | 299.00K | 299.00K | 299.00K | 299.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 24.90M | 26.47M | 28.14M | 29.62M | 31.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 43.57M | 47.96M | 43.15M | 44.75M | 47.39M |
| Total Liabilities | 125.00M | 140.62M | 192.21M | 198.47M | 200.35M |
|
|
|||||
| Common Stock & APIC | 1.71B | 1.70B | 1.69B | 1.68B | 1.68B |
| Retained Earnings | -1.21B | -1.19B | -1.15B | -1.12B | -1.08B |
| Treasury Stock & Other | -45.30M | -45.24M | -47.88M | -47.97M | -18.82M |
| Total Common Equity | 454.60M | 471.72M | 489.33M | 510.26M | 577.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 454.60M | 471.72M | 489.33M | 510.26M | 577.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 454.60M | 471.72M | 489.33M | 510.26M | 577.32M |
|
|
|||||